DaVita Inc (DVA)
163.08
+0.82
(+0.51%)
USD |
NYSE |
Sep 27, 16:00
163.03
-0.05
(-0.03%)
Pre-Market: 20:00
DaVita SG&A Expense (TTM): 1.509B for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 1.509B |
March 31, 2024 | 1.505B |
December 31, 2023 | 1.474B |
September 30, 2023 | 1.452B |
June 30, 2023 | 1.441B |
March 31, 2023 | 1.392B |
December 31, 2022 | 1.355B |
September 30, 2022 | 1.298B |
June 30, 2022 | 1.226B |
March 31, 2022 | 1.209B |
December 31, 2021 | 1.195B |
September 30, 2021 | 1.177B |
June 30, 2021 | 1.247B |
March 31, 2021 | 1.265B |
December 31, 2020 | 1.248B |
September 30, 2020 | 1.221B |
June 30, 2020 | 1.157B |
March 31, 2020 | 1.116B |
December 31, 2019 | 1.103B |
September 30, 2019 | 1.093B |
June 30, 2019 | 1.131B |
March 31, 2019 | 1.120B |
December 31, 2018 | 1.135B |
September 30, 2018 | 1.132B |
June 30, 2018 | 1.069B |
Date | Value |
---|---|
March 31, 2018 | 1.068B |
December 31, 2017 | 1.064B |
September 30, 2017 | 1.084B |
June 30, 2017 | 1.218B |
March 31, 2017 | 1.342B |
December 31, 2016 | 1.465B |
September 30, 2016 | 1.168B |
June 30, 2016 | 1.115B |
March 31, 2016 | 1.076B |
December 31, 2015 | 1.031B |
September 30, 2015 | 1.399B |
June 30, 2015 | 1.369B |
March 31, 2015 | 1.319B |
December 31, 2014 | 1.262B |
September 30, 2014 | 1.224B |
June 30, 2014 | 1.207B |
March 31, 2014 | 1.176B |
December 31, 2013 | 1.176B |
September 30, 2013 | 1.131B |
June 30, 2013 | 1.024B |
March 31, 2013 | 968.89M |
December 31, 2012 | 889.88M |
September 30, 2012 | 802.79M |
June 30, 2012 | 787.51M |
March 31, 2012 | 738.51M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
1.093B
Minimum
Sep 2019
1.509B
Maximum
Jun 2024
1.284B
Average
1.247B
Median
SG&A Expense (TTM) Benchmarks
Quest Diagnostics Inc | 1.643B |
Universal Health Services Inc | 7.425B |
Encompass Health Corp | 3.007B |
Boston Scientific Corp | 5.431B |
Stryker Corp | 7.329B |